The American Cancer Society now recommends routine prostate cancer screening for men aged 50 to 69.
Men at average risk should be tested every two years, while those at higher risk-such as Black men or those with a family history of the disease-should begin screening at age 45 and test annually.
The guidance, released on Thursday, marks a reversal from the organization's 2010 recommendation, which left screening decisions to shared decision-making between patients and physicians.
The new guidelines also outline a stepped approach for abnormal results, advising repeat PSA testing before moving to MRI or biomarker tests, and reserving biopsy for cases with high suspicion of cancer.
For men diagnosed with low-risk prostate cancer, active surveillance is recommended as the initial management strategy.
Prostate cancer is expected to affect nearly 334,000 men in the United States this year, with more than 36,000 deaths projected.